Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hirosaki Lifescience Innovation is a Japanese biotechnology company specializing in the research, development, and commercialization of high-purity proteoglycans derived from salmon nasal cartilage. The company utilizes proprietary extraction technologies developed in collaboration with Hirosaki University to produce functional ingredients for the global nutraceutical and cosmetic markets. Their primary business focus involves the application of proteoglycans in addressing joint health, skin rejuvenation, and inflammatory conditions. As a central entity in the Aomori regional innovation ecosystem, the company bridges academic research in health big data with industrial manufacturing to promote longevity and wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hirosaki Lifescience Innovation.